Haidong Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haidong Li has a total of 253 co-authors. Here are the top co-authors by number of shared publications:
- Juyoung Yoon
Department of Chemistry and Nanoscience Ewha Womans University Seoul Republic of Korea
26 shared publications - Xiaojun Peng
Dalian University of Technology
22 shared publications - Jingyun Wang
State Key Laboratory of Fine Chemicals Dalian University of Technology 2 Linggong Road, Hi‐Tech Zone Dalian 116024 China
17 shared publications Shuang Zeng
State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Dalian University of Technology, 2 Linggong Road, Hi-tech Zone, Dalian 116024, China
10 shared publications- Qixian Chen
Innovation Center of Yangtze River Delta Zhejiang University Jiaxing Zhejiang China
9 shared publications - Jiangli Fan
Dalian University of Technology
8 shared publications
Latest Publications
- 23 September 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (39) , 42416-42431
Photodynamic Hijacking of APE1 Converts Tumor Defenses into Therapeutic Vulnerabilities via a Bidirectionally Gated Prodrug
Photodynamic therapy (PDT) for melanoma is chronically undermined by adaptive resistance, a long-overlooked challenge rooted in coordinated antioxidant buffering and DNA repair defenses. Herein, we propose a novel photodynamic sabotage approach that converts tumor defenses into therapeutic vulnerabilities by hijacking one important defense hub, the APE1 protein. This was achieved through creating a bidirectionally gated theranostic prodrug, APE-BDP, which covalently links an iodine-engineered BODIPY to the APE1 inhibitor CRT through a photocleavable bridge. Beyond pioneering the master regulator APE1, as a photodynamic target, the molecular design strategically repurposes the inherent nitro group on CRT as an endogenous quencher that establishes a photoinduced electron transfer process to silence the iodinated BODIPY. Meanwhile, the steric bulk of the conjugate concurrently physically blocks the CRT–APE1 engagement. This bidirectional gating mechanism ensures reciprocal deactivation in the dark. A single green light trigger initiates near-instantaneous (∼100% within minutes) and synchronous liberation of both warheads, enabling a cooperative dual assault that potently disrupts redox homeostasis and inactivates the APE1-mediated DNA repair machinery. This concerted hijacking of the defense network within the tumor triggers multiple cell death pathways. After formulation into a dissolvable microneedle patch for localized delivery, the system effectively suppressed tumor growth in melanoma models with minimal systemic toxicity. This work establishes that the photodynamic hijacking of key regulatory proteins via intelligent molecular engineering offers a potential design strategy to subvert PDT treatment resistance.
- 23 September 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (39) , 42416-42431
Photodynamic Hijacking of APE1 Converts Tumor Defenses into Therapeutic Vulnerabilities via a Bidirectionally Gated Prodrug
Photodynamic therapy (PDT) for melanoma is chronically undermined by adaptive resistance, a long-overlooked challenge rooted in coordinated antioxidant buffering and DNA repair defenses. Herein, we propose a novel photodynamic sabotage approach that converts tumor defenses into therapeutic vulnerabilities by hijacking one important defense hub, the APE1 protein. This was achieved through creating a bidirectionally gated theranostic prodrug, APE-BDP, which covalently links an iodine-engineered BODIPY to the APE1 inhibitor CRT through a photocleavable bridge. Beyond pioneering the master regulator APE1, as a photodynamic target, the molecular design strategically repurposes the inherent nitro group on CRT as an endogenous quencher that establishes a photoinduced electron transfer process to silence the iodinated BODIPY. Meanwhile, the steric bulk of the conjugate concurrently physically blocks the CRT–APE1 engagement. This bidirectional gating mechanism ensures reciprocal deactivation in the dark. A single green light trigger initiates near-instantaneous (∼100% within minutes) and synchronous liberation of both warheads, enabling a cooperative dual assault that potently disrupts redox homeostasis and inactivates the APE1-mediated DNA repair machinery. This concerted hijacking of the defense network within the tumor triggers multiple cell death pathways. After formulation into a dissolvable microneedle patch for localized delivery, the system effectively suppressed tumor growth in melanoma models with minimal systemic toxicity. This work establishes that the photodynamic hijacking of key regulatory proteins via intelligent molecular engineering offers a potential design strategy to subvert PDT treatment resistance.
- Open Access
- 23 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (36) , 17319-17331
A dual-lock strategy for tumor-specific pyroptosis activation plus gas synergism
This work presents a gas‑synergistic dual‑lock pyroptosis inducer that enables tumor‑specific recognition and efficient ICD induction via GSH/NIR‑triggered photodynamic amplification, offering a new approach for multifunctional tumor immunotherapy.
- 23 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (36) , 17319-17331
Open AccessA dual-lock strategy for tumor-specific pyroptosis activation plus gas synergism
This work presents a gas‑synergistic dual‑lock pyroptosis inducer that enables tumor‑specific recognition and efficient ICD induction via GSH/NIR‑triggered photodynamic amplification, offering a new approach for multifunctional tumor immunotherapy.
- 25 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (31) , 22847-22860
Adsorption-Based Aggregation-Induced Emission on Nanoparticles: A Promising Strategy for Generic Homogeneous Fluorescence Assay Platforms
Aggregation-induced emission (AIE), a “zero background” luminescent phenomenon, shows great potential for fluorescent analytical methods. Traditionally, AIE luminogen aggregation is achieved by modifying solvent polarity. However, analyte concentration variation in trace analysis cannot alter solvent polarity, making this approach incompatible with fluorescent analytical methods and limiting the exploitation of AIE’s potential. Given the widespread use of adsorption in molecular recognition, we propose that adsorption-based aggregation-induced emission (adAIE) could unify molecular recognition and signal transduction, facilitating the development of simple, general fluorescent assays. This study seeks to elucidate the adAIE mechanism and significantly broaden its application in analytical chemistry. The adsorption capacities of various tetraphenylethylene compounds (TPEs) on two styryl-based nanopolymers and their corresponding induced fluorescence intensities were systematically investigated. The findings indicate that adAIE intensity increases with greater adsorption, with rapid changes observed during the initial adsorption phase, and displays behavior distinct from poor solvent driven AIE. Additionally, a quantitative relationship was established between adAIE sensitivity and its key influencing factors, specifically the adsorption capacity and optical parameters (ε and φ) of TPEs. Using this relationship, we developed a general, mix-and-measure, “turn-on” fluorescent assay to detect nanoplastics in water samples. Furthermore, a selective, homogeneous fluorescent assay for dopamine detection was achieved by combining adAIE with competitive adsorption based on boronate affinity. This work clarifies the adAIE mechanism, highlights its rapid response and high compatibility, opens new possibilities for AIE in analytical applications. Integrating universal molecular recognition (adsorption) with efficient signal transduction (AIE) provides separation-free and highly sensitive fluorescence sensing platforms.
- 25 July 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (31) , 22847-22860
Adsorption-Based Aggregation-Induced Emission on Nanoparticles: A Promising Strategy for Generic Homogeneous Fluorescence Assay Platforms
Aggregation-induced emission (AIE), a “zero background” luminescent phenomenon, shows great potential for fluorescent analytical methods. Traditionally, AIE luminogen aggregation is achieved by modifying solvent polarity. However, analyte concentration variation in trace analysis cannot alter solvent polarity, making this approach incompatible with fluorescent analytical methods and limiting the exploitation of AIE’s potential. Given the widespread use of adsorption in molecular recognition, we propose that adsorption-based aggregation-induced emission (adAIE) could unify molecular recognition and signal transduction, facilitating the development of simple, general fluorescent assays. This study seeks to elucidate the adAIE mechanism and significantly broaden its application in analytical chemistry. The adsorption capacities of various tetraphenylethylene compounds (TPEs) on two styryl-based nanopolymers and their corresponding induced fluorescence intensities were systematically investigated. The findings indicate that adAIE intensity increases with greater adsorption, with rapid changes observed during the initial adsorption phase, and displays behavior distinct from poor solvent driven AIE. Additionally, a quantitative relationship was established between adAIE sensitivity and its key influencing factors, specifically the adsorption capacity and optical parameters (ε and φ) of TPEs. Using this relationship, we developed a general, mix-and-measure, “turn-on” fluorescent assay to detect nanoplastics in water samples. Furthermore, a selective, homogeneous fluorescent assay for dopamine detection was achieved by combining adAIE with competitive adsorption based on boronate affinity. This work clarifies the adAIE mechanism, highlights its rapid response and high compatibility, opens new possibilities for AIE in analytical applications. Integrating universal molecular recognition (adsorption) with efficient signal transduction (AIE) provides separation-free and highly sensitive fluorescence sensing platforms.
- Open Access
- 23 July 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (39) , e4883627
Molecular Engineering Boosts Photon‐Activated Immunotherapy for Prostate Cancer Through Concurrent Pyroptosis and cGAS‐STING Pathway Activation
Prostate cancer therapy is often limited by metastasis, drug resistance, and systemic toxicity. Photodynamic immunotherapy (PDIT) offers a promising alternative, yet its efficacy depends on photosensitizers that can simultaneously generate reactive oxygen species (ROS) and activate antitumor immunity. Herein, three thiophene (T) dyes based on triphenylamine (D) and N ‐ethyl‐benzoselenazolium iodide (Se) (DTSe)‐based photosensitizers were molecularly engineered by modulating the π‐conjugated structure. Incorporation of a carbazole unit affords DZTSe with suppressed fluorescence, enlarged Huang–Rhys factor, reduced singlet‐triplet energy gap, and prolonged triplet‐state lifetime, resulting in enhanced ROS generation. Notably, DZTSe exhibits multi‐organelle localization in the endoplasmic reticulum and mitochondria, concurrently inducing pyroptosis and activating the cGAS‐STING pathway. This dual stress‐immune activation reprograms the tumor microenvironment and enables effective eradication of primary tumors and suppression of distant lesions in vivo, providing a molecular blueprint for immune‐activating photosensitizers.
- 23 July 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (39) , e4883627
Open AccessMolecular Engineering Boosts Photon‐Activated Immunotherapy for Prostate Cancer Through Concurrent Pyroptosis and cGAS‐STING Pathway Activation
Prostate cancer therapy is often limited by metastasis, drug resistance, and systemic toxicity. Photodynamic immunotherapy (PDIT) offers a promising alternative, yet its efficacy depends on photosensitizers that can simultaneously generate reactive oxygen species (ROS) and activate antitumor immunity. Herein, three thiophene (T) dyes based on triphenylamine (D) and N ‐ethyl‐benzoselenazolium iodide (Se) (DTSe)‐based photosensitizers were molecularly engineered by modulating the π‐conjugated structure. Incorporation of a carbazole unit affords DZTSe with suppressed fluorescence, enlarged Huang–Rhys factor, reduced singlet‐triplet energy gap, and prolonged triplet‐state lifetime, resulting in enhanced ROS generation. Notably, DZTSe exhibits multi‐organelle localization in the endoplasmic reticulum and mitochondria, concurrently inducing pyroptosis and activating the cGAS‐STING pathway. This dual stress‐immune activation reprograms the tumor microenvironment and enables effective eradication of primary tumors and suppression of distant lesions in vivo, providing a molecular blueprint for immune‐activating photosensitizers.
- Open Access
- 23 July 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (39) , e4883627
Molecular Engineering Boosts Photon‐Activated Immunotherapy for Prostate Cancer Through Concurrent Pyroptosis and cGAS‐STING Pathway Activation
Prostate cancer therapy is often limited by metastasis, drug resistance, and systemic toxicity. Photodynamic immunotherapy (PDIT) offers a promising alternative, yet its efficacy depends on photosensitizers that can simultaneously generate reactive oxygen species (ROS) and activate antitumor immunity. Herein, three thiophene (T) dyes based on triphenylamine (D) and N ‐ethyl‐benzoselenazolium iodide (Se) (DTSe)‐based photosensitizers were molecularly engineered by modulating the π‐conjugated structure. Incorporation of a carbazole unit affords DZTSe with suppressed fluorescence, enlarged Huang–Rhys factor, reduced singlet‐triplet energy gap, and prolonged triplet‐state lifetime, resulting in enhanced ROS generation. Notably, DZTSe exhibits multi‐organelle localization in the endoplasmic reticulum and mitochondria, concurrently inducing pyroptosis and activating the cGAS‐STING pathway. This dual stress‐immune activation reprograms the tumor microenvironment and enables effective eradication of primary tumors and suppression of distant lesions in vivo, providing a molecular blueprint for immune‐activating photosensitizers.
- 23 July 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (39) , e4883627
Open AccessMolecular Engineering Boosts Photon‐Activated Immunotherapy for Prostate Cancer Through Concurrent Pyroptosis and cGAS‐STING Pathway Activation
Prostate cancer therapy is often limited by metastasis, drug resistance, and systemic toxicity. Photodynamic immunotherapy (PDIT) offers a promising alternative, yet its efficacy depends on photosensitizers that can simultaneously generate reactive oxygen species (ROS) and activate antitumor immunity. Herein, three thiophene (T) dyes based on triphenylamine (D) and N ‐ethyl‐benzoselenazolium iodide (Se) (DTSe)‐based photosensitizers were molecularly engineered by modulating the π‐conjugated structure. Incorporation of a carbazole unit affords DZTSe with suppressed fluorescence, enlarged Huang–Rhys factor, reduced singlet‐triplet energy gap, and prolonged triplet‐state lifetime, resulting in enhanced ROS generation. Notably, DZTSe exhibits multi‐organelle localization in the endoplasmic reticulum and mitochondria, concurrently inducing pyroptosis and activating the cGAS‐STING pathway. This dual stress‐immune activation reprograms the tumor microenvironment and enables effective eradication of primary tumors and suppression of distant lesions in vivo, providing a molecular blueprint for immune‐activating photosensitizers.
- Open Access
- 21 July 2026
- Published by Wiley in Smart Molecules
- p. e70085
Endocytosis‐independent cytosolic entry of messenger RNA via fluorous bilayer zippering attenuating Toll‐like receptor signaling and enables ischemic tissue salvage
A fundamental constraint of conventional messenger RNA (mRNA) delivery systems is their obligatory trafficking through endosomal–lysosomal compartments, wherein cargo degradation and activation of endosomal Toll‐like receptors precipitate substantial translational attrition and deleterious inflammatory cascades. We herein report a chemically engineered platform that circumvents these limitations ab initio. Through strategic perfluoro‐acylation of branched polyethyleneimine (PEI, 25 kDa) with pentafluoropropionic anhydride, we install approximately 26 fluoro‐amide “zipper” moieties per polymer chain that orchestrate direct, energy‐independent trans‐bilayer translocation without recruitment of clathrin, caveolae, or lipid raft microdomains—thereby precluding lysosomal entrapment and catabolism. Bio‐orthogonal copper‐free click chemistry between azide‐ and dibenzocyclooctyne (DBCO)‐terminated PEI‐F derivatives, coupled with redox‐labile disulfide crosslinkers, engenders polyplexes of exceptional extracellular stability that undergo quantitative glutathione‐triggered disassembly within the cytosolic milieu. This endosome‐evasive entry mechanism effectively sequesters single‐stranded mRNA from Toll‐like receptor 3, TLR7, and TLR8 surveillance, establishing a “TLR‐attenuated” delivery paradigm characterized by undetectable interferon‐α, interferon‐β, TNF‐α, and IL‐6 induction. In human umbilical vein endothelial cells, GFP‐mRNA transfection exceeds 90% fluorescent positivity with 4.8‐fold superior luciferase expression relative to Lipofectamine™ 3000, whilst maintaining >95% viability. Therapeutic translatability is demonstrated in a murine hindlimb ischemia model, wherein a single 10 μg intramuscular dose of mVEGF‐A polyplexes restores blood perfusion to 118% of baseline within 28 days—representing marked superiority over the commercial gold standard and effectuating complete tissue salvage without necrosis. Comprehensive hematological and immunological profiling corroborates the absence of hematotoxicity, systemic inflammation, or innate immune activation. This modular, purely synthetic platform resolves the classical stability–availability paradox whilst eliminating the immunogenic liabilities inherent to endocytic delivery, furnishing a readily translatable scaffold for precision regenerative medicine.
- 21 July 2026
- Published by Wiley in Smart Molecules
- p. e70085
Open AccessEndocytosis‐independent cytosolic entry of messenger RNA via fluorous bilayer zippering attenuating Toll‐like receptor signaling and enables ischemic tissue salvage
A fundamental constraint of conventional messenger RNA (mRNA) delivery systems is their obligatory trafficking through endosomal–lysosomal compartments, wherein cargo degradation and activation of endosomal Toll‐like receptors precipitate substantial translational attrition and deleterious inflammatory cascades. We herein report a chemically engineered platform that circumvents these limitations ab initio. Through strategic perfluoro‐acylation of branched polyethyleneimine (PEI, 25 kDa) with pentafluoropropionic anhydride, we install approximately 26 fluoro‐amide “zipper” moieties per polymer chain that orchestrate direct, energy‐independent trans‐bilayer translocation without recruitment of clathrin, caveolae, or lipid raft microdomains—thereby precluding lysosomal entrapment and catabolism. Bio‐orthogonal copper‐free click chemistry between azide‐ and dibenzocyclooctyne (DBCO)‐terminated PEI‐F derivatives, coupled with redox‐labile disulfide crosslinkers, engenders polyplexes of exceptional extracellular stability that undergo quantitative glutathione‐triggered disassembly within the cytosolic milieu. This endosome‐evasive entry mechanism effectively sequesters single‐stranded mRNA from Toll‐like receptor 3, TLR7, and TLR8 surveillance, establishing a “TLR‐attenuated” delivery paradigm characterized by undetectable interferon‐α, interferon‐β, TNF‐α, and IL‐6 induction. In human umbilical vein endothelial cells, GFP‐mRNA transfection exceeds 90% fluorescent positivity with 4.8‐fold superior luciferase expression relative to Lipofectamine™ 3000, whilst maintaining >95% viability. Therapeutic translatability is demonstrated in a murine hindlimb ischemia model, wherein a single 10 μg intramuscular dose of mVEGF‐A polyplexes restores blood perfusion to 118% of baseline within 28 days—representing marked superiority over the commercial gold standard and effectuating complete tissue salvage without necrosis. Comprehensive hematological and immunological profiling corroborates the absence of hematotoxicity, systemic inflammation, or innate immune activation. This modular, purely synthetic platform resolves the classical stability–availability paradox whilst eliminating the immunogenic liabilities inherent to endocytic delivery, furnishing a readily translatable scaffold for precision regenerative medicine.
Constructing a NIR AIEgen Based on the Novel Molecular Framework for Imaging Lipid Droplet Accumulation in Parkinson's Disease Mouse Brain
Parkinson's disease (PD) pathogenesis has been linked to the aberrant accumulation of lipid droplets (LDs). Understanding the situation of LD accumulation and its dynamic variations in the neural tissues of PD patients is therefore crucial for deciphering the underlying pathophysiological mechanisms of this neurodegenerative disorder. Developing a specific fluorescent probe for LDs that can also function within the brain presents a significant challenge. This study introduces a NIR (near‐infrared) emitting fluorescent probe, QCN‐TP, through step‐by‐step molecular design strategy, based on a novel framework of dye, characterized by multiple advantageous properties, including polarity sensitivity, a substantial Stokes shift (150–280 nm), and aggregation‐induced emission (AIE). The probe, QCN‐TP, demonstrates remarkable sensitivity and selectivity in the recognition of LD accumulation, with enhanced deep tissue penetration capabilities. Notably, QCN‐TP effectively monitors both the presence of intracellular LDs and their dynamic content variations in MPP + ‐induced PD cell models. Furthermore, the probe enables in vivo imaging of abnormal LD accumulation in the brain tissue of PD model mice. This probe offers a useful tool for real‐time monitoring of lipid dynamics, with potential applications in PD research and drug discovery.
Constructing a NIR AIEgen Based on the Novel Molecular Framework for Imaging Lipid Droplet Accumulation in Parkinson's Disease Mouse Brain
Parkinson's disease (PD) pathogenesis has been linked to the aberrant accumulation of lipid droplets (LDs). Understanding the situation of LD accumulation and its dynamic variations in the neural tissues of PD patients is therefore crucial for deciphering the underlying pathophysiological mechanisms of this neurodegenerative disorder. Developing a specific fluorescent probe for LDs that can also function within the brain presents a significant challenge. This study introduces a NIR (near‐infrared) emitting fluorescent probe, QCN‐TP, through step‐by‐step molecular design strategy, based on a novel framework of dye, characterized by multiple advantageous properties, including polarity sensitivity, a substantial Stokes shift (150–280 nm), and aggregation‐induced emission (AIE). The probe, QCN‐TP, demonstrates remarkable sensitivity and selectivity in the recognition of LD accumulation, with enhanced deep tissue penetration capabilities. Notably, QCN‐TP effectively monitors both the presence of intracellular LDs and their dynamic content variations in MPP + ‐induced PD cell models. Furthermore, the probe enables in vivo imaging of abnormal LD accumulation in the brain tissue of PD model mice. This probe offers a useful tool for real‐time monitoring of lipid dynamics, with potential applications in PD research and drug discovery.
- 10 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Glutathione-Triggered Unleashing of Protease K Prodrug Suppressed Primary Tumors and Its Metastasis with Stimulated Anti-tumor Immunity
Protein therapeutics have garnered significant enthusiasm for oncological applications, owing to their exquisite specificity and intrinsic bioactivity. Yet, proteins remain constrained by limited transcellular permeability and proteolytic susceptibility during delivery. To circumvent these impediments, we engineered a redox-responsive protein prodrug, RP-ss-PK, via covalent conjugation of cytotoxic proteinase K (PK) to a multifunctional polymer, RGD-PEG-ss-NPC. This linear hetero-difunctional PEG scaffold contains a cyclic RGD peptide at the α-terminus for integrin-mediated tumor targeting and a 4-nitrophenyl ethyl carbonate (NPC) group at the ω-terminus for site-specific conjugation to amine-rich lysine residues on PK. An internal disulfide linker (-ss-) renders the prodrug cleavable in the presence of intracellular glutathione (GSH). Upon systemic administration, RP-ss-PK selectively accumulates within neoplastic lesions via RGD-integrin (αvβ3/αvβ5) recognition. Endocytosis exposes the disulfide tether to the cytosolic glutathione milieu, triggering reductive cleavage and subsequent liberation of native, fully active PK. The unleashed protease initiates indiscriminate proteolysis that precipitates rapid tumor cell death, accompanied by plasma-membrane permeabilization. This membrane disruption facilitates the extracellular release of damage-associated molecular patterns (DAMPs), thereby igniting anti-tumor immunity and remodeling the tumor microenvironment. Collectively, this prodrug paradigm not only amplifies the tumor-selective delivery of protein therapeutics but also exemplifies a facile, broadly applicable strategy for intracellular activation and functional restoration of protein cargos. Our findings establish RP-ss-PK as a versatile platform poised for the targeted protein treatment of diverse pathologies.
- 10 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Glutathione-Triggered Unleashing of Protease K Prodrug Suppressed Primary Tumors and Its Metastasis with Stimulated Anti-tumor Immunity
Protein therapeutics have garnered significant enthusiasm for oncological applications, owing to their exquisite specificity and intrinsic bioactivity. Yet, proteins remain constrained by limited transcellular permeability and proteolytic susceptibility during delivery. To circumvent these impediments, we engineered a redox-responsive protein prodrug, RP-ss-PK, via covalent conjugation of cytotoxic proteinase K (PK) to a multifunctional polymer, RGD-PEG-ss-NPC. This linear hetero-difunctional PEG scaffold contains a cyclic RGD peptide at the α-terminus for integrin-mediated tumor targeting and a 4-nitrophenyl ethyl carbonate (NPC) group at the ω-terminus for site-specific conjugation to amine-rich lysine residues on PK. An internal disulfide linker (-ss-) renders the prodrug cleavable in the presence of intracellular glutathione (GSH). Upon systemic administration, RP-ss-PK selectively accumulates within neoplastic lesions via RGD-integrin (αvβ3/αvβ5) recognition. Endocytosis exposes the disulfide tether to the cytosolic glutathione milieu, triggering reductive cleavage and subsequent liberation of native, fully active PK. The unleashed protease initiates indiscriminate proteolysis that precipitates rapid tumor cell death, accompanied by plasma-membrane permeabilization. This membrane disruption facilitates the extracellular release of damage-associated molecular patterns (DAMPs), thereby igniting anti-tumor immunity and remodeling the tumor microenvironment. Collectively, this prodrug paradigm not only amplifies the tumor-selective delivery of protein therapeutics but also exemplifies a facile, broadly applicable strategy for intracellular activation and functional restoration of protein cargos. Our findings establish RP-ss-PK as a versatile platform poised for the targeted protein treatment of diverse pathologies.
- 21 April 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (17) , 13144-13152
Peroxynitrite-Activated Valproic Acid Precursor for Monitoring Oxidative Stress and Reducing Epileptic Seizures in an Epilepsy Model
Epilepsy is a chronic neurological disorder characterized by recurrent seizures, which poses a significant threat to human health. Increasing evidence indicates that the pathological mechanism of epilepsy is closely related to the presence of peroxynitrite (ONOO-). To address this issue, we have developed a dual-molecule release precursor, DVN, with different functional components, which consists of a responsive group, a reporter segment, and a drug molecule, for monitoring peroxynitrite. Based on in vitro assays, DVN exhibits several advantages, including high specificity, a rapid response time (120 s), and a dual release function, and is not affected by other reactive oxygen species. When this precursor is activated by peroxynitrite, valproic acid (VPA) is released, which is a broad-spectrum antiepileptic drug that can reduce seizure occurrences; a near-infrared (NIR) reporter unit is formed synchronously using DVN, and we successfully tracked the fluctuations of endogenous and exogenous ONOO- in SH-SY5Y cells and achieved significant spatiotemporal resolution. Moreover, DVN can clearly display the changes of endogenous ONOO- in SH-SY5Y cells. Crucially, DVN helps to perform fluorescence imaging of the ONOO- concentration in epilepsy models, while also reducing the seizure levels in mice and shortening their seizure latency, for the first time. These findings indicate that DVN provides a promising tool for the diagnosis and treatment of epilepsy by imaging the fluctuations of ONOO-, and offers a reliable method for studying the treatment of epilepsy.
- 21 April 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (17) , 13144-13152
Peroxynitrite-Activated Valproic Acid Precursor for Monitoring Oxidative Stress and Reducing Epileptic Seizures in an Epilepsy Model
Epilepsy is a chronic neurological disorder characterized by recurrent seizures, which poses a significant threat to human health. Increasing evidence indicates that the pathological mechanism of epilepsy is closely related to the presence of peroxynitrite (ONOO-). To address this issue, we have developed a dual-molecule release precursor, DVN, with different functional components, which consists of a responsive group, a reporter segment, and a drug molecule, for monitoring peroxynitrite. Based on in vitro assays, DVN exhibits several advantages, including high specificity, a rapid response time (120 s), and a dual release function, and is not affected by other reactive oxygen species. When this precursor is activated by peroxynitrite, valproic acid (VPA) is released, which is a broad-spectrum antiepileptic drug that can reduce seizure occurrences; a near-infrared (NIR) reporter unit is formed synchronously using DVN, and we successfully tracked the fluctuations of endogenous and exogenous ONOO- in SH-SY5Y cells and achieved significant spatiotemporal resolution. Moreover, DVN can clearly display the changes of endogenous ONOO- in SH-SY5Y cells. Crucially, DVN helps to perform fluorescence imaging of the ONOO- concentration in epilepsy models, while also reducing the seizure levels in mice and shortening their seizure latency, for the first time. These findings indicate that DVN provides a promising tool for the diagnosis and treatment of epilepsy by imaging the fluctuations of ONOO-, and offers a reliable method for studying the treatment of epilepsy.
- Open Access
- 24 January 2026
- Published by Wiley in AIChE Journal
- Vol. 72 (5)
A rational strategy to optimize photodrugs by Molecular Dynamics simulations for killing drug‐resistant Gram‐negative bacteria
Antimicrobial resistance has become a major threat to human health, particularly for Gram‐negative bacteria such as Acinetobacter baumannii and Klebsiella pneumoniae . Disruption of membrane integrity is regarded as a promising antimicrobial strategy that does not induce distinct drug resistance, while increasing the internalization of drug doses and mitigating efflux mechanisms. In this study, relying on molecular dynamics (MD) simulations to optimize and confirm the membrane‐disrupting activity of photodrugs, we fabricated a series of monomeric (TC n ) and dimeric (TC n T) photodrugs ( n = 4, 8, 12, and 16), with different alkyl chain lengths, enabling their differing bacterial membrane rupture capabilities of inherent. Notably, based on MD simulations and in vitro experiments, TC 8 T exhibited enhanced antibacterial efficacy against multiple drug‐resistant Gram‐negative strains upon white light irradiation, including clinically difficult‐to‐treat strains. More importantly, TC 8 T demonstrated robust antimicrobial activity and promoted tissue reconstruction in murine models of wound infection and post‐tumor‐resection mixed infections.
- 24 January 2026
- Published by Wiley in AIChE Journal
- Vol. 72 (5)
Open AccessA rational strategy to optimize photodrugs by Molecular Dynamics simulations for killing drug‐resistant Gram‐negative bacteria
Antimicrobial resistance has become a major threat to human health, particularly for Gram‐negative bacteria such as Acinetobacter baumannii and Klebsiella pneumoniae . Disruption of membrane integrity is regarded as a promising antimicrobial strategy that does not induce distinct drug resistance, while increasing the internalization of drug doses and mitigating efflux mechanisms. In this study, relying on molecular dynamics (MD) simulations to optimize and confirm the membrane‐disrupting activity of photodrugs, we fabricated a series of monomeric (TC n ) and dimeric (TC n T) photodrugs ( n = 4, 8, 12, and 16), with different alkyl chain lengths, enabling their differing bacterial membrane rupture capabilities of inherent. Notably, based on MD simulations and in vitro experiments, TC 8 T exhibited enhanced antibacterial efficacy against multiple drug‐resistant Gram‐negative strains upon white light irradiation, including clinically difficult‐to‐treat strains. More importantly, TC 8 T demonstrated robust antimicrobial activity and promoted tissue reconstruction in murine models of wound infection and post‐tumor‐resection mixed infections.